You Asked: Haemophilus and AFM

Slides:



Advertisements
Similar presentations
Introduction to Pandemic Influenza
Advertisements

Swine Influenza April 30, 2009 Bill Mason, MD Jill Hoffman, MD Dawn England, MPH.
Overcoming Disease in Your Community Gail Baker, RN Megan Davies, MD Gina Holland, RN Jenny Snow, MPH.
Influenza-like Illness Visits & Influenza Labs as of December 10, 2012.
Mosquito-borne Arbovirus Surveillance in West Virginia Rachel Radcliffe, DVM, MPH CDC Career Epidemiology Field Officer Division of Infectious Disease.
Poliomyelitis Surveillance in Ireland 4 th April, 2014.
Reportable Disease Update Local Health Department Nurses Meeting June 20, 2013 T.J. Sugg, MPH.
IPV IPV Rapidly produces high level of protective antibodies No risk of vaccine associated illness No interference from other enteroviruses. I.P.V. produces.
Testing algorithms used at Bureau of Labs Michigan Department of Community Health Information on testing algorithms for processing and reporting serological.
Role of the laboratory in disease surveillance
EBOLA Virus Disease August 22, What is Ebola Virus Disease (EVD)? Ebola virus disease (also known as Ebola hemorrhagic fever) is a severe, often-fatal.
Outbreak Investigation: The First 48 Rachel Radcliffe, DVM, MPH Career Epidemiology Field Officer Division of Infectious Disease Epidemiology West Virginia.
Principles of Outbreak Management
Hepatitis web study H EPATITIS W EB S TUDY Hepatitis A: Epidemiology Presentation Prepared by: David Spach, MD and Nina Kim, MD Last Updated: May 31, 2011.
Ethics Conference on Asian Flu Pandemic Ethical considerations among Response to H1N1 Pandemic in China China CDC, CFETP Huilai Ma, Guang Zeng.
West Nile Virus Jo Hofmann, MD State Epidemiologist for Communicable Disease Washington State Department of Health Focus on clinical aspects of human infection.
Outbreak Reporting Sponsored by Navy and Marine Corps Public Health Center U.S. Army Public Health Command Air Force School of Aerospace Medicine Presented.
Swine Flu Tool Kit Responding to the threat. Principles of Swine Flu Toolkit 1 Rapid Identification of Acute Respiratory Disease Identify Risk Factors.
Traveling Fever The following slides represent a realistic public health crisis event and you are charged with developing first messages for the public.
Information Exchange for Detection and Monitoring: Clinical Care to Health Departments Janet J Hamilton, MPH Florida Department of Health.
Public Health Issues of Interest Seasonal Influenza Seasonal Norovirus Middle East Respiratory Syndrome Coronavirus Novel Influenza (A/H7N9) David H. Trump,
PIDPIC SOT Working Group Pediatric Infectious Diseases Program for Immunocompromised Hosts.
Dr. Zhen XU Branch of Respiratory Disease Prevention and Control Division for Disease Control and Emergency Response Chinese Center for Disease Control.
SEARO –CSR Early Warning and Surveillance System Module Case Definitions.
Health Security and Emergencies Ebola Response 13 October 2014.
Severe Acute Respiratory Syndrome (SARS) and Preparedness for Biological Emergencies 27 April 2004 Jeffrey S. Duchin, M.D. Chief, Communicable Disease.
SARS. What is SARS? Severe Acute Respiratory Syndrome Respiratory illness Asia, North America, and Europe Previously unrecognized coronavirus.
The Vermont Department of Health Overview of Pandemic Influenza Regional Pandemic Planning Summits 2006 Guidance Support Prevention Protection.
Disease Surveillance and Epidemiology (DSE) – WHO Indonesia 1 |1 | International Health Regulations (2005) and EWARS Dr Nirmal Kandel, MBBS, MA, MPH Disease.
Liberia Field Epidemiology Training Programme (LFETP)Liberia Field Epidemiology Training Programme LFETP) FIELD WORK 2 -Expanded Surveillance Report- -Measles.
Liberia Field Epidemiology Training Programme (LFETP)Liberia Field Epidemiology Training Programme LFETP) FIELD WORK 2 -Expanded Surveillance Report- -Case.
Severe Acute Respiratory Syndrome (SARS) and Preparedness for Biological Emergencies 27 April 2004 Jeffrey S. Duchin, M.D. Chief, Communicable Disease.
Public Health Perspective on SARS Diagnostics Stephen M. Ostroff Deputy Director National Center for Infectious Diseases, CDC.
Overview of Influenza New York City Department of Health and Mental Hygiene.
Current Pandemic H1N1 Updates in the Philippines Department of Health, Philippines Juan M. Lopez, MD, PGradDipPH, MPH Aldrin Q. Reyes, RN.
Epi Program Overview Disease Surveillance and Reporting.
Infection Prevention Update – March 2016 Marie Kassai, RN, MPH, CIC.
Using Surveillance Indicators for Vaccine-Preventable Diseases: National Notifiable Diseases Surveillance System Sandra W. Roush, MT, MPH National.
APIC Chapter 13 Journal Club March 16, 2015 Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults NEJM – July 30, :5 Presented.
Using Vaccine Preventable Disease Surveillance Indicators for Evaluation (of Reporting to CDC) Denise Woods-Stout Vaccine Preventable Disease Surveillance.
Infection Control Q and A APIC Greater NY Chapter 13 May 17, 2017 Beth Nivin BA MPH NYC DOHMH Communicable Disease Program
Infection Prevention eBug Bytes December 2016
Acute Flaccid Myelitis (AFM)
Outbreak Investigations
Overview of National Surveillance for Vaccine-Preventable Diseases
Nasreen Abdullah, MD, MPH
World Health Organization
23 November, 2018 Update on measles & rubella surveillance in the WHO African Region – progress and challenges Dr Richard Luce WHO/IST-Central 5th African.
Epidemiological Modeling to Guide Efficacy Study Design Evaluating Vaccines to Prevent Emerging Diseases An Vandebosch, PhD Joint Statistical meetings,
Monitoring HPV vaccine impact in Connecticut
Introduction To Medical Technology
The Role of NICs in Influenza Surveillance
Investigation & Outbreak Tools
School Nurse Meeting December 10, 2018
Module 1 Introduction to rotavirus disease and vaccine
Module 1 Introduction to rotavirus disease and vaccine
Haemophilus Influenzae
Infection Prevention eBug Bytes December 2016
Module 1 Introduction to rotavirus disease and vaccine
Module 1 Introduction to rotavirus disease and vaccine
Vaccine Preventable Disease Surveillance and Investigation
Improving Haemophilus influenzae Serotype Reporting
Module 1 Introduction to rotavirus disease and vaccine
Specimen Submission Requirements Update and Lab Discussion
Using Whole Genome Sequencing Analysis in California
Acute Flaccid Myelitis: A Clinical Overview for 2019
Varicella Vaccine Efficacy Estimates
Lab Results + RVCT Notification=
National Immunization Conference
Surveillance: From Patient to CDC
Presentation transcript:

You Asked: Haemophilus and AFM Rachel Wiseman, MPH VPD Epidemiologist

Haemophilus Influenzae: What’s New for 2016

What is an H. flu serotype? The H. flu bacteria is typically encapsulated. There are six types of capsules (a through f). Some H. flu bacteria do not have a capsule at all. Those are referred to as non-typeable. Of course, if no one looks for a capsule, then the H. flu is considered untyped.

Overview of Changes Changed the Texas Administrative Code to make all Haemophilus Influenzae (H. flu) reportable. Consistent with national standards Allows for better understanding of the epidemiology of H. flu in Texas and how vaccine impacts that Reduces potential for missed cases Texas Administrative Code also updated to mandate submission of H. flu isolates to DSHS Lab on children under 5 years of age only DSHS will still accept (sterile site) isolates on H. flu patients of all ages.

New Case Definition All invasive Haemophilus influenzae disease is now reportable, regardless of serotype. H. flu type b is still reportable. Types a, c, d, e, and f are also now reportable. Non-typeable H. flu is reportable. Untyped H. flu is reportable. Non-invasive Haemophilus influenzae is still NOT reportable.

Probable Case Status Still the Same Meningitis with detection of H. flu type b antigen in CSF. Per CDC, this test is unreliable in urine or serum, so only CSF can be used for case classification This test only applies to type b. I’m not sure why.

Updated Documents Updated H. flu case track Updated case criteria guide Updated case investigation guidelines DEG was updated Sept 2015 NBS was already designed for all H. flu, no changes made

Follow up of H. flu Cases Our primary interest is still H. flu, type b—especially in children under 5 This is because only type b is vaccine preventable AND Only children under 5 are vaccinated against H. flu, type b

Prioritization Children under 5 with H. flu, type b ~1% of reports Children under 5 with non-b H. flu ~12% of reports Anyone 5 or older with H. flu, type b Anyone 5 or older with non-b H. flu

H. Flu Cases under 5 Determine case definition is met Ensure isolate has been sent to DSHS If H. Flu type b, determine need for contact PEP Obtain complete vaccination history Complete all questions on case track Enter everything into NBS

H. Flu Cases over 5 If type b If NOT type b Confirm case definition Obtain vaccination history Determine need for contact PEP Enter what you have into NBS If NOT type b Just confirm case definition, serogroup and enter into NBS

Control Measure Concerns Type b, ANY AGE Determine if children under 5 have been exposed Prophylaxis may be required depending on age and vaccine and immunologic status of contacts NOT Type b, ANY AGE Recommend good hand hygiene

Questions?

Acute Flaccid Myelitis: What? Why? How?

What is Acute Flaccid Myelitis (AFM)? Rapid onset of limb(s) weakness and distinct abnormalities of the spinal cord gray matter Mostly caused by West Nile, polio, and flaviviruses AFM is a subset of acute flaccid paralaysis (AFP) Surveillance for AFP is the worldwide gold standard for polio surveillance. The US does not do AFP surveillance. Global expected AFP incidence: 1/100,000 children <15 years old

AFM Epidemiology Basically unknown Aug 2014-Feb 2015, 111 cases reported in 34 states in patients <22 No fatalities 62% had not fully recovered, 37% had not improved Possibly EVD-68 related, but no pathogens isolated in CSF on any patient 12 cases had respiratory specimens positive for viruses besides EVD-68 CDC estimates <20 cases of AFM per year in a state (all ages)

National AFM Surveillance Plan CDC has requested states to surveil for AFM CSTE made a case definition, but decided not to make AFM nationally notifiable CDC made an investigation form CDC has agreed to do testing CDC published a clinical reminder for clinicians to continue vigilance for AFM CDC has a neurologist to help, because AFM is hard Some states have started the process to make AFM notifiable in their states

Texas’s AFM Surveillance Plan Texas published CSTE’s case definition in the 2016 Epi Case Criteria Guide Texas adapted the CDC’s investigation form and put it on the IDCU site Texas sent out a health advisory requesting clinicians to report Texas wrote an AFM chapter for the EAID Guidelines Texas has begun the work to include AFM in NBS Texas plans to send a letter to neurologists asking them to report Texas has opened up discussion about making AFM a reportable condition

Investigation Plan Read the AFM chapter in the Guidelines Give the neurologist the AFM investigation form and ask them to complete it and return it Request a copy of the MRI results Ask what (viral/bacterial) testing has been done and what the results are Ask the provider to collect specimens (stool, CSF, NP swab, see Guidelines) Report to Rachel who will facilitate testing with CDC

Investigation Plan, Part 2 No public health intervention needed UNLESS: If pathogen is identified, follow up (PEP, treatment) may be warranted If reportable pathogen is identified, follow up and further investigation and data entry will be needed If cluster or outbreak detected (regardless of pathogen), alerts to medical community (and possibly other entities) may be needed

The Point Baseline data Ensure US can detect polio Difficult to determine significance of 2014 outbreak with no baseline data Ensure US can detect polio Random fact: Guillain-Barre is not AFM, but it is AFP Important if Zika becomes established AND if Zika does cause Guillain-Barre Guillain-Barre is not reportable as AFM, but the underlying condition may be reportable it and of itself

Questions?